217 related articles for article (PubMed ID: 8613399)
1. Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model.
Menzies BE; Kernodle DS
Infect Immun; 1996 May; 64(5):1839-41. PubMed ID: 8613399
[TBL] [Abstract][Full Text] [Related]
2. Functionally inactive S. aureus alpha-toxin containing a single amino acid substitution: potential usefulness as a vaccine.
Bhakdi S; Jursch R; Bröker M; Ronneberger H; Hungerer KD
Behring Inst Mitt; 1994 Dec; (95):80-4. PubMed ID: 7755512
[TBL] [Abstract][Full Text] [Related]
3. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
Uppalapati SR; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
[TBL] [Abstract][Full Text] [Related]
4. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
[TBL] [Abstract][Full Text] [Related]
5. Site-directed mutagenesis of the alpha-toxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model.
Menzies BE; Kernodle DS
Infect Immun; 1994 May; 62(5):1843-7. PubMed ID: 8168947
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.
Oscherwitz J; Cease KB
PLoS One; 2015; 10(1):e0116882. PubMed ID: 25635901
[TBL] [Abstract][Full Text] [Related]
7. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
[TBL] [Abstract][Full Text] [Related]
8. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.
Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D
J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200
[TBL] [Abstract][Full Text] [Related]
10. [Protective effects of active immunization against alpha hemolysin of Staphylococcus aureus].
Wleklinski CG; Neubüser U; Ronneberger H; Hungerer KD; Schaeg W; Blobel H
Zentralbl Veterinarmed B; 1982 Sep; 29(8):596-603. PubMed ID: 7180248
[No Abstract] [Full Text] [Related]
11. Antibody-Mediated Protection against Staphylococcus aureus Dermonecrosis: Synergy of Toxin Neutralization and Neutrophil Recruitment.
Yang C; Ruiz-Rosado JD; Robledo-Avila FH; Li Z; Jennings RN; Partida-Sanchez S; Montgomery CP
J Invest Dermatol; 2021 Apr; 141(4):810-820.e8. PubMed ID: 32946878
[TBL] [Abstract][Full Text] [Related]
12. In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.
Oscherwitz J; Muñoz-Planillo R; Yu F; Núñez G; Cease KB
Mol Immunol; 2014 Jul; 60(1):62-71. PubMed ID: 24769493
[TBL] [Abstract][Full Text] [Related]
13. Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia.
Adhikari RP; Karauzum H; Sarwar J; Abaandou L; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Devi VS; Shulenin S; Warfield KL; Aman MJ
PLoS One; 2012; 7(6):e38567. PubMed ID: 22701668
[TBL] [Abstract][Full Text] [Related]
14. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
Adhikari RP; Thompson CD; Aman MJ; Lee JC
Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174
[TBL] [Abstract][Full Text] [Related]
16. Effects of adjuvants on the immune response of staphylococcal alpha toxin and capsular polysaccharide (CPS) in rabbit.
Han HR; Park HM
J Vet Med Sci; 2000 Mar; 62(3):237-41. PubMed ID: 10770593
[TBL] [Abstract][Full Text] [Related]
17. Vaccine protection against Staphylococcus aureus pneumonia.
Bubeck Wardenburg J; Schneewind O
J Exp Med; 2008 Feb; 205(2):287-94. PubMed ID: 18268041
[TBL] [Abstract][Full Text] [Related]
18. [In vitro and in vivo efficacy of a toxin-neutralizing human staphylococcal immunoglobulin].
Hungerer KD; Ronneberger H
Behring Inst Mitt; 1990 Oct; (86):170-84. PubMed ID: 2252461
[TBL] [Abstract][Full Text] [Related]
19. A human monoclonal antibody with the capacity to neutralize Staphylococcus aureus alpha-toxin.
Heveker N; Hansen A; Hungerer KD; von Baehr R; Glaser RW
Hum Antibodies Hybridomas; 1994; 5(1-2):18-24. PubMed ID: 7858179
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
